Willkommen, schön sind Sie da!
Logo Ex Libris

Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II

  • Kartonierter Einband
  • 484 Seiten
(0) Erste Bewertung abgeben
Alle Bewertungen ansehen
1978 Annual Plenary Meeting of the European Organization for Research on Treatment of Cancer, Paris, June 1978A prospective random... Weiterlesen
CHF 150.00
Print on Demand - Auslieferung erfolgt in der Regel innert 4 bis 6 Wochen.
Bestellung & Lieferung in eine Filiale möglich


1978 Annual Plenary Meeting of the European Organization for Research on Treatment of Cancer, Paris, June 1978

A prospective randomized clinical trial of treatment with vincristine, cyclophosphamide, methotrexate and 5-fluorouracil after conventional curative treatment for stage II breast cancer is described. The results at 2 years are recorded together with details of toxicity. Future plans are discussed briefly. Acknowledgement We wish to acknowledge the participation of all the collaborators in this study, the co-ordinator Dr. ERICA MANSBACHER and the support of Action Cancer in Belfast. References 1. Ahmann, D. L. , O'Connell, M. J. , Hahn, R. G. , Bisel, H. F. , Lee, R. A. , Edmonson, J. H. : An evaluation of early or delayed adjuvant chemotherapy in premenopause1 patients with advanced breast cancer undergoing oophorectomy. New Engl. J. Med. 297, 356-360 (1977) 2. Ahmann, D. L. , Scanlon, P. W. , Bisel, H. F. , Edmonson, J. H. , Frytak, S. , Payne, W. S. , O'Fallon, J. R. , Hahn, R. J. , Ingle, J. N. , O'Connell, M. J. , Rubin, J. : Repeated adjuvant chemotherapy with Phenyl-alanine mustard, or 5-Fluorouracil, Cyclophosphamide and Prednisone with or without radiation after mastectomy for breast cancer. Lancet 1978//, 893-896 3. Bonadonna, G. , Rossi, A. , Valagussa, P. , Banfi, A. , Veronesi, U. : The CMF program for operable breast cancer with positive axillary nodes. Cancer 39, 2904-2915 (1977) 4. Edelstyn, G. A. , Bates, T. S. , Brinkley, D. , Macrae, K. D. , Spittle, M. , Wheeler, T. : Comparison of 5-day, I-day and 2-day cyclical combination chemotherapy in advanced breast cancer.

B. Wilms' Tumor and Sarcomas.- Wilms' Tumor: Assessment and Treatment of Residual Disease.- Adjuvant Therapy in the Management of Osteosarcoma: Need for Critical Reassessment.- Adjuvant Therapy of Operable Primary Osteosarcoma-Cancer and Leukemia Group B Experience.- Adriamycin in the Adjuvant Treatment of Operable Osteosarcoma.- Randomized Trial of Adjuvant Chemotherapy in Osteogenic Osteosarcoma Comparison of Altering Sequential Administrations of High Doses of Adriamycin, Methotrexate, and Cyclophosphamide with a 6-Month Administration of High-Dose Adriamycin Followed by a Low-Dose Semicontinuous Chemotherapy. EORTC-Osteosarcoma Working Party Group.- Biochemistry of the Citrovorum Factor Rescue Effect in Normal Bone Marrow Cells After High-Dose Methotrexate Treatment: Implications for Therapy.- Adjuvant Interferon Treatment of Human Osteosarcoma.- Current Results With a Combined Treatment Approach to Localized Ewing's Sarcoma.- EORTC/GTO Adjuvant Chemotherapy Program for Primary Ewing's Sarcoma: Results at 5 Years.- Adjuvant Treatment of Soft Tissue Sarcoma in Children and Adults.- C. Breast Carcinoma.- Place and Role of Radiotherapy After Surgery for Breast Cancer.- Combined Modality Management of Operable Breast Cancer.- Treatment of Early Breast Cancer With Adriamycin-Cyclophosphamide With or Without Radiation Therapy: Initial Results of a Brief and Effective Adjuvant Program.- Results of a Randomized Trial of Prophylactic Chemotherapy in T3T4 Breast Cancer Patients Previously Treated by Radiotherapy.- Four Drug Combination Cytotoxic Chemotherapy Following Surgery for Breast Cancer.- Pilot Study on Adjuvant Chemotherapy and Hormonal Therapy for Irradiated Inoperable Breast Cancer.- Ovarian Irradiation and Prednisone Following Surgery and Radiotherapy for Carcinoma of the Breast.- Adjuvant Therapy of Stage II, III Breast Cancer.- Randomized Trial With Poly A Poly U as Adjuvant Therapy Complementing Surgery in Patients With Breast Cancer: In vitro Study of Cellular Immunity.- Levamisole: As Adjuvant to Cyclic Chemotherapy in Breast Cancer.- D. Ovary, Uterus and Testis Cancer.- Laparoscopy and Peritoneal Cytology as Markers in the Follow-Up of Ovarian Epithelial Tumors.- Radiotherapy in Ovarian Cancer for Post-Surgical Minimal Residual Disease.- Chemotherapeutic Sensitivity of Minimal Residual Disease Following Surgical Excision of Ovarian Carcinoma.- Chemoimmunotherapy for Advanced Ovarian Carcinoma With Adriamycin-Cyclophosphamide ± BCG: Early Report of a Southwest Oncology Group Study.- Active Specific Immunotherapy in Ovarian Cancer.- Clinical Studies on PSK: Combination Therapy of PSK With Radiation in Cancer of the Uterine Cervix.- Irradiation as Adjuvant Therapy in the Management of Testicular Tumors.- Adjuvant Chemotherapy in Embryonal Carcinoma of the Testis.- Adjuvant Chemotherapy of Testicular Carcinoma: Need for Evaluation of Curative Strategies.- Results of Cytostatic Therapy of Metastasizing Testicular Tumors.- E. Digestive Tract Tumors.- Treatment of Patients With Gastric Cancer by Surgery, Radiotherapy, and Chemotherapy: Preliminary Results of an EORTC Randomized Study.- Chemotherapy for Known Residual Disease After Resection of Gastric and Colorectal Cancer.- Adjuvant Treatment With Razoxane (ICRF 159) Following Resection of Cancer of the Stomach..- Adjuvant Chemotherapy in Large-Bowel Cancer: Demonstration of Effectiveness of Single Agent Chemotherapy in a Prospectively Controlled, Randomized Trial.- Ongoing Trials in the Surgical Adjuvant Management of Colorectal Cancer.- Clinical Studies on PSK: Combination Therapy of PSK With Surgery and Chemotherapy.- F. Bronchus Carcinoma.- Role of Radiotherapy as an Adjuvant Therapy in Operable Bronchus Carcinoma.- Influence of Postoperative Radiotherapy on Local Recurrence and Survival of Bronchial Epidermoid Carcinoma With Regard to Nodal Status: Preliminary Results of the EORTC Protocol 08741.- Preliminary Trends of the EORTC Study Comparing Postoperative Chemotherapy, Immunotherapy, Chemoimmunotherapy or Abstention in Squamous Cell Bronchial Carcinoma.- Adjuvant Chemotherapy of Post-Surgical Minimal Residual Bronchial Carcinomas.- Attempt at Immunotherapy With Living BCG in Patients With Bronchus Carcinoma.- Adjuvant Therapy With Levamisole in Resectable Lung Cancer.- Specific Active Imunochemotherapy in Lung Cancer: A Survival Study.- Patterns of Recurrence After Regional BCG Immunotherapy of Bronchial Cancer.- Intrapleural BCG in Operable Lung Cancer.- G. Head and Neck Tumors.- Adjuvant Chemoimmunotherapy of Head and Neck Cancer.- Adjuvant Treatment of Tongue and Floor of the Mouth Cancers.- First Results of a Randomized Trial on Immunotherapy of Head and Neck Tumors.- Adjuvant Trial of Levamisole in Patients With Squamous Cancer of the Head and Neck: A Preliminary Report.- H. Urological Tumors.- Adjuvant Chemotherapy Following Radical Radiotherapy in T3 Bladder Carcinoma.- Adjuvant Therapy of T1 Bladder Carcinoma: Preliminary Results of an EORTC Randomized Study.- I. Melanoma.- Adjuvant Chemotherapy or Chemoimmunotherapy in the Management of Primary Malignant Melanoma of Level III, IV, or V.- Immunotherapy for Recurrent Malignant Melanoma: Efficacy of BCG in Prolonging the Postoperative Disease-Free Interval and Survival.- Results of a Nonrandomized Trial in Malignant Melanoma Patients (Clark's Stages IIIV) Treated by Post-Surgical Chemoimmunotherapy.- Value of Adjuvant Therapy With Bacille Calmette Guerin (BCG) or Dimethyl Triazeno Imidazole Carboximide (DTIC) in the Control of Minimal Residual Disease in Stage II Melanoma.- Controlled Study for Prolonged Chemotherapy, Immunotherapy, and Chemotherapy Plus Immunotherapy as an Adjuvant to Surgery in Malignant Melanoma (Trial 6) Preliminary Report.- Adjuvant Therapy in Malignant Melanoma: A Trial of Immunotherapy, Chemotherapy, and Combined Treatment.- Malignant Melanoma (Stage I): A Clinical Trial of Adjuvant BCG Immunotherapy.- J. Neurological Tumors.- Adjuvant Chemotherapy With Nitrosourea Compounds Following Surgery Plus Radiotherapy in Glioblastoma Multiforme.- Treatment of Adult Malignant Gliomas.- Adjuvant Chemotherapy in Malignant Brain Gliomas.- Adjuvant Therapy for Residual Disease in Children With Medulloblastoma.- Radiochemotherapy of Postoperative Minimal Residual Disease in Neuroblastoma.- K. Tumors Not Yet Submitted to Adjuvant Chemotherapy and Immunotherapy Trials.- Adjuvant Systemic Therapy of Cancer: Rationale for Future Trials.- Some New Chemotherapeutic Agents and Combinations Possibly Available for New Adjuvant Therapies of Minimal Disease.- Third Generation of Systemic Adjuvants of Immunity: Experimental Basis for Adjuvant Combinations.- Interrelationship Between Chemotherapy and Immunotherapy in the Treatment of Disseminated Disease.- Concluding Remarks.


Titel: Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II
Untertitel: Adjuvant Therapies of the Various Primary Tumors
EAN: 9783642813344
ISBN: 3642813348
Format: Kartonierter Einband
Herausgeber: Springer Berlin Heidelberg
Genre: Medizin
Anzahl Seiten: 484
Gewicht: 828g
Größe: H244mm x B170mm x T25mm
Jahr: 2012
Auflage: Softcover reprint of the original 1st ed. 1979

Weitere Produkte aus der Reihe "Recent Results in Cancer Research"